IBA H1 FY26 net result swings to profit of €9.3 million; net sales rise 6% to €323.7 million

Reuters2026/08/27 05:00

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

IBA posted H1 2026 net sales up 6% to EUR 323.7 million, with gross margin widening 4.2 percentage points to 33.7%.
Net result swung to profit of EUR 9.3 million, yielding EPS of EUR 0.32.
Adjusted EBIT rose 66% to EUR 17.6 million, driven by improved execution and profitability mix in Proton Therapy.
Equipment order intake jumped to EUR 176 million, with IBA Clinical more than doubling to EUR 148 million on five rooms sold.
FY 2026 adjusted EBIT guidance reiterated at at least EUR 32 million, with management citing continued momentum in Proton Therapy and RadioPharma Solutions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IBA - Ion Beam Applications SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608270100OMX_____CNEWS_EN_GNW1001259518_en) on August 27, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

IBA H1 FY26 net result swings to profit of €9.3 million; net sales rise 6% to €323.7 million

You may also like

Crypto prices